Wednesday, May 24, 2017 8:36:09 PM
Partner at Hestia Investments
Director, Sutura Therapeutics
http://www.suturatherapeutics.com/
Keith Foster
Chief Scientific Officer at Sutura Therapeutics.
Sutura Therapeutics own the intellectual property of a technologies to enhance the delivery of antisense oligonucleotides. Sutura Therapeutics' pipeline includes a DMD product using this technology.
E-mail Keith.Foster@suturatherapeutics.com
I am a translational biologist with 21 years’ experience in developing gene, cell and pharmaceutical medicines for Duchenne muscular dystrophy (DMD) and metabolic diseases. I currently run a state of the art research lab at the University of Reading that is able to facilitate medicine development and subsequent analyses in pre-clinical disease models.
Current programs included:
1. Optimising delivery of antisense oligonucleotides.
2. Viral and pharmaceutical mediated approaches to counter oxidative stress.
3. Novel approaches to induce immune tolerance to neo-antigens.
4. Antisense oligonucleotide mediated approaches to muscle augmentation for muscular dystrophy and metabolic diseases.
Recent GEGP News
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 09/20/2024 07:51:58 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 07/23/2024 04:14:45 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM